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Objectives: To assess the risk factors of cervical cancer and the feasibility and acceptability 
of a visual inspection with acetic acid (VIA) screening method in a primary health center in 
Khartoum, Sudan.
Methods: A cross-sectional prospective pilot study of 100 asymptomatic women living in 
Khartoum State in Sudan was carried out from December 2008 to January 2009. The study was 
performed at the screening center in Khartoum. Six nurses and two physicians were trained 
by a gynecologic oncologist. The patients underwent a complete gynecological examination 
and filled in a questionnaire on risk factors and feasibility and acceptability. They were screened 
for cervical cancer by application of 3%–5% VIA. Women with a positive test were referred 
for colposcopy and treatment.
Results: Sixteen percent of screened women were tested positive. Statistically significant 
associations were observed between being positive with VIA test and the following variables: 
uterine cervix laceration (odds ratio [OR] 18.6; 95% confidence interval [CI]: 4.64–74.8), 
assisted vaginal delivery (OR 13.2; 95% CI: 2.95–54.9), parity (OR 5.78; 95% CI: 1.41–23.7), 
female genital mutilation (OR 4.78; 95% CI: 1.13–20.1), and episiotomy (OR 5.25; 95% 
CI: 1.15–23.8). All these associations remained statistically significant after adjusting for age, 
educational level, employment, and potential confounding factors such as smoking, number of 
sexual partners, and use of contraceptive method. Furthermore, the VIA screening method was 
found to be feasible and acceptable to participants.
Conclusion: This pilot study showed that women who have uterine cervix laceration, assisted 
vaginal delivery, female genital mutilation, or episiotomy are at an increased risk of cervical 
cancer. It also showed that VIA is a feasible and acceptable cervical cancer screening method 
in a primary health care setting.
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Background
Cervical cancer is one of the leading causes of death for middle-aged women in 
the developing world, yet it is almost completely preventable if precancerous 
lesions are identified and treated in a timely manner.1 There are many risk factors 
for cervical cancer, which include human papillomavirus infection,2,3 early age at 
first sexual intercourse,2,4,5 increased number of sexual partners,2,5 long-term use of 
oral contraceptives,6 smoking2,3,7,8 history of infertility,9 intrauterine device,9 high 
parity,10,11–13 trauma with pregnancy,14,15 low education,16 and low socioeconomic 
level.17 Factors reducing risk of cervical cancer include male circumcision,2,3,7,10,18 use 
of condoms,3,5 abstinence from sexual intercourse during menses time, and celibate 
status.19International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Cervical cancer screening based on cytological examination 
is largely unavailable in developing countries or available only 
to a small, select group of women in private facilities, maternal 
child health sites, or family planning clinics, thereby missing 
the age groups at the highest risk for precancerous lesions.1 
The   failure of a conventional cytology-based approach to 
reducing cervical cancer in developing countries,   particularly in 
Africa, can be attributed to several factors, including scarcity of 
trained, skilled professionals, lack of resources, and expense.20 
There is interest in a new screening method using visual 
techniques to identify cervical cancer.
These visual techniques can be divided into two general 
categories. One is the simple screening method, such as 
visual screening by use of acetic acid (VIA), during which the 
cervix is visualized with the naked eye under a direct source 
of light, and application of a solution of 3%–5% acetic acid 
that is used as a chemical contrast agent to highlight areas 
of   metaplastic changes. The mechanism of the VIA test is 
a chemical reaction between neoplasia acetic acid. When 
neoplastic tissue is stained with acetic acid (3%–5%), it 
uptakes the acetic acid and changes to a whitish color (aceto-
white area). If this occurs, a positive VIA test is reported, and 
it indicates that there is a malignant change in the aceto-white 
area in the cervix, which is precisely around the squamoco-
lumnar junction, the main anatomical site where cervical 
malignant neoplasia develops.21
VIA has been evaluated in a number of large   clinical 
  trials and is considered to be a possible alternative to 
  cervical   cytology for primary cervical cancer screening in 
  low-resource settings. The advantages of VIA compared 
with cervical cytology are that it is inexpensive, it does 
not require a laboratory infrastructure, and it provides 
an immediate result, allowing use of “screen and treat” 
  protocols.22 The simple visual screening methods are being 
evaluated as an alternative to cytology in low-resource 
  settings where screening using cervical cytology is not 
feasible. Multiple studies have shown VIA to have sensitivity 
similar to that of cervical cytology but much lower specific-
ity for   identifying women with   high-grade cervical cancer 
lesion and squamous intraepithelial lesion.23 VIA showed a 
sensitivity of 79% (95% confidence interval [CI] 73%–85%) 
and 83% (95% CI 77%–89%), and a specificity of 85% (95% 
CI 81%–89%) and 84% (95% CI 80%–88%) for CIN2+ and 
CIN3+, respectively.24 VIA can be easily implemented as a   
quick and inexpensive test in unsophisticated health care 
  settings. Also, this method can provide the result of screening 
immediately, and the patient can be treated with cryotherapy 
at the same time.
The aim of the present study conducted among women in 
Khartoum State, Sudan, was to assess risk factors of cervical 
cancer and the feasibility and acceptability of a single-visit 
method for cervical cancer screening by using VIA in a 
primary health care setting.
Material and methods
Six nurses and two supervisors were trained on prescreening 
counseling, data collection and VIA screening methods in 
a primary health care center setting by an investigator and     
gynecological oncology consultant from the Radiation and 
Isotopes Center in Khartoum. A campaign to raise public 
awareness about cervical cancer among the local women was 
performed. Posters and pamphlets were distributed to women 
in public places at primary health centers, shopping centers, 
and transport centers. A program about cervical cancer and 
VIA screening methods was presented by a gynecological 
oncologist and investigator at the local radio broadcasting 
station. In addition, in the context of Friday and Sunday 
prayers, Imams in mosques and clerks in churches talked 
about cervical cancer screening and encouraged women to 
participate in the screening project.
House-to-house visits were used to recruit participants. 
During the home visits, pamphlets were distributed, and 
women were informed about cervical cancer and about the 
opportunity for prevention and treatment by early   detection. 
Healthy nonpregnant women aged 25–50 years living in 
Khartoum State in Sudan who were voluntarily willing 
to participate in screening were included in the study. 
Eligible women were given an appointment for screening 
at the cervical cancer screening clinic, and questionnaires 
containing sociodemographic, obstetric, and gynecologic 
variables and other risks factors were filled in. At the 
  screening clinic, a counseling session about the screening test 
procedures was delivered either at an individual or a group 
level. Written informed consent was signed by all women 
who had agreed to have a screening test.
The VIA test was performed by adding 5 mL of acetic acid 
(vinegar) to 95 mL of distal water in a sterile kidney dish to 
compose 5% acetic acid. Women were asked to lie on their 
back in a lithotomy position, in the presence of a good source 
of light. The external genitals were inspected and cleaned with 
use of gauze and normal saline, and then a sterile bivalve 
speculum was inserted into the vagina. The vagina wall and 
cervix were inspected for the presence of tumors and other 
diseases. Any mucus or discharge at the cervix was cleaned 
with the use of sterile cotton. Then, the squamocolumnar junc-
tion was determined and acetic acid was applied. VIA positive International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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was defined as well-marginated, raised, opaque, aceto-white 
lesion at the   squamocolumnar junction.21 VIA-positive women 
were referred to the oncology gynecologist at the Radiation 
and Isotopes Center for treatment. VIA-negative women were 
assured and asked to have the test repeated after 5 years. 
Women who had other diseases such as bacterial or fungal 
infection were also treated at the screening center. The treat-
ment was offered free of charge.
Statistical analysis
Descriptive statistics was used to characterize participants; 
Chi-square, and Fischer’s exact tests were used to assess 
differences in proportions between dichotomous outcome 
and explanatory variables; and the Student’s t-test was used 
to assess differences in means of age. Odds ratios (ORs) 
were calculated to assess associations between risk factors 
and diagnosis of cervical cancer with use of the VIA test. 
Significance level was set at P , 0.05 and CI at 95%. All 
statistical analyses were performed using Stata Version 9.2 
(StataCorp, College Station, TX).
Results
One hundred and fifty women aged 25–50 years were 
invited to participate in the cervical cancer screening 
project, and 100 women attended the screening clinic 
(response rate of 67%). Table 1 shows the characteristics 
of the subjects. The mean age was 35 years, 36% had no 
education, and 33% were employed. Sixty-four percent of 
the participating women had had genital mutilation. Sixty 
percent were parous, 80% of them had spontaneous vaginal 
delivery, 62% were episiotomized, and 12% had laceration. 
Only 30% of screened women used contraceptive methods, 
but 97% practised in the lower part of the body. Of the male 
partners, 98% were circumcised.
Table 2 describes the association between risk factors 
and cervical cancer diagnosis with the use of VIA. A highly 
statistically significant association was observed between 
cervical cancer and uterine cervix laceration (OR 18.6, 95% 
CI: 4.64–74.8). Assisted vaginal delivery was also strongly 
related to cervical cancer (OR 13.2; 95% CI: 2.95–54.9).
Risk of cervical cancer was significantly higher among 
parous than among nulliparous women (OR 5.78; 95% 
CI: 1.41–23.7). Moreover, this study showed that there was 
a statistically significant association between a positive 
VIA result and female genital mutilation (OR 4.78; 95% 
CI: 1.13–20.1). Furthermore, the result showed a statistically 
significant association between episiotomy and a positive VIA 
results (OR 5.25; 95% CI: 1.15–23.8). All these statistically 
significant associations remained after adjusting for other 
factors, including age, educational level, and employment, 
and potential confounding factors, such as smoking, number 
of sexual partners, and use of contraceptive methods. No 
statistically significant findings were found for male partner 
circumcision, use of contraception method, or use of cosmetic 
smoking in the lower part of the body.
This study revealed a high proportion of accessibility to 
the screening method. About 98% of screened women were 
satisfied with their decision to be screened. A total of 81.6% 
Table  1  Characteristics  of  the  participants  in  cervical  cancer 
screening with the visual inspection with acetic acid (VIA) method 
in Khartoum State, Sudan
Characteristics Total VIA test
(n = 100) Negative  
(n = 84)
Positive   
(n = 16)
N (%) N (%) N (%)
Age
Mean age 37.2 34.1 40.3
#35 years 52 (52) 45 (54) 7 (44)
$36 years 48 (48) 39 (46) 9 (56)
Education
Yes 36 (36) 32 (38.1) 4 (25)
no 64 (64) 52 (61.9) 12 (75)
Employment
Yes 33 (33) 29 (34.5) 4 (25)
no 67 (67) 55 (65.5) 12 (75)
Smoking
Yes 4 (4) 2 (2.4) 2 (12.5)
no 96 (96) 82 (97.6) 14 (87.5)
Female genital mutilation
Yes 90 (90) 76 (90.5) 14 (87.5)
no 10 (10) 8 (9.5) 2 (12.5)
Male partner circumcision
Yes 98 (98) 83 (98.8) 15 (93.7)
no 2 (2) 1 (1.2) 1 (6.3)
Contraception
Yes 30 (30) 27 (32.1) 3 (18.8)
no 70 (70) 57 (67.9) 13 (81.2)
Practice of duhan lower part of the body
Yes 97 (97) 82 (81.5) 15 (93.7)
no 3 (3) 2 (2.5) 1 (6.3)
Parity
nulliparous 40 (40) 38 (45.2) 2 (12.5)
Parous 60 (60) 46 (54.8) 14 (87.5)
Vaginal delivery (out of parous n = 60)
Spontaneous 48 (75) 42 (91.3) 6 (41.9)
Assisted 12 (25) 4 (8.7) 8 (57.1)
Episiotomy (out of parous n = 60)
Yes 37 (61.7) 24 (28.2) 12 (9.8)
no 23 (38.3) 21 (17.8) 2 (6.2)
Uterine cervix laceration
Yes 7 (7) 2 (2.4) 5 (31.3)
no 93 (93) 82 (97.6) 11 (68.7)International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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of participants stated that the visit to the screening clinic took 
less than 45 minutes (Table 3). Treatment was postponed due 
to a lack of resources for two patients (12.5%).
Discussion
In this pilot study of 100 women in Khartoum State, Sudan, 
16% of women had a positive VIA result. The major risk 
  factors were uterine cervix laceration, assisted   vaginal 
delivery, female genital mutilation, and episiotomy.   Screening 
was feasible and acceptable, both in terms of participa-
tion rate and the experience of women. The slow natural 
development of cervical cancer is crucial to a screening 
method that identifies dysplasia and prevents its progression 
to invasive carcinoma. The cervical cancer prevalence of 16% 
was the same as in Nigeria; higher than in Kenya, Ghana 
(14%), and Latin America (12%); and lower than in South 
Africa and Zimbabwe, where the VIA test was positive in 
26% of the study population.25–30
The results strongly suggest that incidents causing trauma 
to the uterine cervix are risk factors for cervical cancer in 
Khartoum State. This was true for women with uterine cervix 
laceration, genital mutilation, women who delivered   vaginally, 
women who had had an episiotomy, women who had under-
gone assisted vaginal delivery, and parous women.
Also, earlier episiotomy has been reported as a site for 
implantation and recurrence of cervical cancer in women 
who had cervical cancer during pregnancy and delivered 
vaginally.31–36 It has been reported that metaplastic changes are 
also influenced by the trauma and repair experienced during 
delivery, and increased risk of cervical carcinoma has been 
identified in women who are highly parous.37,38 The results 
of this study revealed that uneducated and   unemployed 
women had high risk of cervical cancer, which are consistent 
with previous studies that show that cervical cancer is more 
prevalent in low-educated and low socioeconomic status 
populations.16,17 Factors such as cosmetic smoking of the 
lower body and partner circumcision are very common 
practices among the sample, which made it impossible to 
study them as risk factors for cervical cancer. This remains 
to be researched in a larger or more varied sample.
The study results provide new risk factors for cervical 
cancer: uterine cervix, assisted vaginal delivery, episiotomy, 
and female genital mutilation. Any trauma to female genital 
organs is a predisposing factor to infection. Episiotomy, 
cervical laceration, and genital mutilation are major types of 
iatrogenic trauma.40 Infection with human papillomavirus is 
a fundamental risk factor for cervical cancer.2,3 The majority 
of women were episiotomized during delivery, and a higher 
number of pregnancies and multiparities were reported as 
risk factors for cervix uteri cancer. Women with these factors 
Table 2 Associations between risk factors and cervical cancer with use of the visual inspection with acetic acid (VIA) screening method 
in Khartoum State, Sudan (n = 100)
Risk factor % VIA (positive)  % VIA (negative)  Odds ratio 95% confidence 
interval
P value
uterine cervix laceration  71.4 11.8 18.6 4.64–74.8 0.001
Assisted vaginal delivery  66.7 12.5 13.2 2.95–58.9 0.003
Parity 23.3 5 5.78 1.41–23.7 0.02
Female genital mutilation 21.9 5.5 4.78 1.13–20.1 0.04
Episiotomy  32.4 8.7 5.25 1.15–23.8 0.05
Male partner circumcision  18.1 50.0 0.18 0.01–2.29 0.3
use of contraception method 10 18.5 0.48 0.13–1.83 0.3
use of cosmetic smoking in lower part of body 18.3 33.3 0.53 0.03–3.96 0.4
Table  3  Acceptability  and  feasibility  of  cervical  cancer  with 
the use of the visual inspection with acetic acid (VIA) screening 
method in Khartoum State, Sudan (n = 98a)
Outcome variable Yes (%) No (%) P value
Satisfied with the decision  
to be screened
96 (97.7) 2 (2.3) 0.0001
Visit to the screening clinic  
took less than 45 minutes
85 (86.7) 13 (13.7) 0.0001
Counseling provided enough  
information about screening
89 (90.8) 9 (9.2) 0.0001
Waiting time before screening  
was less than 20 minutes
82 (83.7) 16 (16.3) 0.0001
Screening test procedure was  
less than 25 minutes 
79 (80.6) 19 (19.4) 0.0001
Counseling provided enough  
information about screening
89 (90.8) 9 (9.2) 0.0001
Test experience was better  
than expected
87 (88.8) 12 (12.4) 0.0001
Was informed immediately about  
the result after the screening test
95 (96.9) 3 (3.1) 0.0001
Recommended screening  
test to other women 
91 (92.9) 7 (7.1) 0.0001
Treatment was offered  
free of charge 
12 (87.5) 2 (12.5) 0.0001
Note: aTwo women did not reply to this part of questionnaire, so they were excluded.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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were about nine times more prone to cervical cancer than 
were women without these factors.Episiotomy is found to be 
one of risk factors for cervical cancer.42, 43 If pregnant women 
diagnosed with cervical cancer are treated prior to delivery 
and go on to have an episiotomy, the cancer cells here will 
undergo metastasis.44
This pilot study showed that over two-thirds of women 
approached took the screening test. One explanation for this 
relatively high participation rate was probably the active 
information campaign. The screening facility was relatively 
easily accessed, and the examination was acceptable for most 
of the women. This finding was equal to that in Thailand,31 
lower than that in the Philippines, and higher than that in 
Ghana.27
The test is very simple and can be used effectively by 
nurses after 2 days of training. It is very cheap, costing about 
US$5 per visit for a 3-year screening strategy.
This study is limited by its small sample size. A large 
sample size is needed to clarify the nature of the observed 
association between cervical cancer and risk factors in these 
results.
Conclusion
This pilot study showed that women in Khartoum State, 
Sudan, who had trauma to their cervix, such as uterine cervix 
laceration, assisted vaginal delivery, female genital mutilation, 
or episiotomy, are at an increased risk of cervical cancer. It also 
showed that VIA is a feasible and acceptable cervical cancer 
screening method in a primary health care setting.
The results showing trauma to the cervix as being a risk 
factor for cervical cancer point to the importance of safe 
delivery facilities and establishing guidelines and standard 
operation procedures for performing assisted vaginal   delivery 
and episiotomy in obstetrics practice. Also, abandonment 
of female genital mutilation can have a great effect in 
  decreasing the incidence of cervical cancer. Additional 
efforts are required in the training of birth attendants on safe 
delivery services and an increase in advocacy and community 
  awareness about female genital mutilation risks. Further 
decisions on the introduction of cervical cancer screening 
in Sudan are critically needed.
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